
Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …
Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

